Influence of multidrug resistance on 18F-FCH cellular uptake in a glioblastoma model

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 8, 2009, Pages 1256-1264

  Vanpouille, Claire ^a   Le Jeune, Nathalie ^a   Kryza, David ^b   Clotagatide, Anthony ^a   Janier, Marc ^b   Dubois, Francis ^a   Perek, Nathalie ^a,c  

^a UNIVERSITÉ JEAN MONNET   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

Author keywords

18F Fluorocholine; Choline metabolism; Drug resistance; Glioblastoma; Tumour aggressiveness

Indexed keywords

ABC TRANSPORTER; CHOLINE DERIVATIVE; CHOLINE KINASE; CHOLINE TRANSPORTER; FLUORINE 18; FLUOROCHOLINE F 18; GLUTATHIONE; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG; CHOLINE; COTRANSPORTER; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUOROCHOLINE; SLC5A7 PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CANCER RESISTANCE; CELL MIGRATION; CHOLINE UPTAKE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; RECEPTOR AFFINITY; WESTERN BLOTTING; ANIMAL; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CHOLINE; CHOLINE KINASE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; PHENOTYPE; SYMPORTERS;

EID: 70349237218     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1101-5     Document Type: Article

References (47)

1. SN Ha J Hochman RP Sheridan 2007 Mini review on molecular modeling of P-glycoprotein (Pgp) Curr Top Med Chem 7 1525 1529 17897039 10.2174/ 156802607782194806 1:CAS:528:DC%2BD2sXhsVOrur3J (Pubitemid 47618065)
2. E Hinoshita T Ushiumi K Taguchi N Kinukawa M Tsunayoshi Y Maehaea, et al. 2000 Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas Clin Cancer Res 6 2401 2407 10873092 1:CAS:528:DC%2BD3cXksVGhsLg%3D
3. Y Nakamura H Sato T Motokura 2006 Development of multidrug resistance due to multiple factors including P-glycoprotein overexpression under K-selection after MYC and HRAS oncogene activation Int J Cancer 118 2448 2454 16353156 10.1002/ijc.21691 1:CAS:528:DC%2BD28XktlGiuro%3D
4. MJ Ruiz-Gomez A Souviron M Martinez-Morillon L Gil 2000 P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine J Physiol Biochem 56 307 312 11321524 1:CAS:528: DC%2BD3MXjtVOit7c%3D
5. MA Barrand T Bagrij SY Neo 1997 Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion Gen Pharmacol 28 639 645 9184795 1:CAS:528:DyaK2sXjt12qsbc%3D (Pubitemid 27244411)
6. N Perek D Denoyer 2002 The multidrug resistance mechanisms and their interactions with the radiopharmaceutical probes used for an in vivo detection Curr Drug Metab 3 97 113 11876578 10.2174/1389200023338107 1:CAS:528: DC%2BD38XhvFKmtbo%3D (Pubitemid 34296312)
7. FJ Sharom 2008 ABC multidrug transporters: structure, function and role in chemoresistance Pharmacogenomics 9 105 127 18154452 10.2217/14622416.9.1.105 1:CAS:528:DC%2BD1cXhtFOjsg%3D%3D (Pubitemid 351560534)
8. G Eliyahu T Kreizman H Degani 2007 Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies Int J Cancer 120 1721 1730 17236204 10.1002/ijc.22293 1:CAS:528:DC%2BD2sXjtFOktL8%3D (Pubitemid 46402874)
9. K Glunde MA Jacobs ZM Bhujwalla 2006 Choline metabolism in cancer: implications for diagnosis and therapy Expert Rev Mol Diagn 6 821 829 17140369 10.1586/14737159.6.6.821 1:CAS:528:DC%2BD2sXmslyruw%3D%3D (Pubitemid 44903998)
10. S Janardhan P Srivani GN Sastry 2006 Choline kinase: an important target for cancer Curr Med Chem 13 1169 1186 16719778 10.2174/092986706776360923 1:CAS:528:DC%2BD28Xks1Krur4%3D
11. V Michel Z Yuan S Ramsubir M Bakovic 2006 Choline transport for phospholipid synthesis Exp Biol Med (Maywood) 231 490 504 1:CAS:528: DC%2BD28XktlCqs78%3D
12. A Rodríguez-González A Ramírez de Molina J Benítez-Rajal JC Lacal 2003 Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets Prog Cell Cycle Res 5 191 201 14593713
13. K Nakagami T Uchido S Ohwada Y Koibuchi Y Morishita 1999 Increased choline kinase activity in 1,2-dimethylhydrazine-induced rat colon cancer Jpn J Cancer Res 90 1212 1217 10622531 1:CAS:528:DyaK1MXns1Ors7o%3D
14. A Ramírez de Molina D Gallego-Ortera J Sarmentero-Estrada D Lagares T Gómez Del Pugar E Bandrés, et al. 2008 Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy Int J Biochem Cell Biol 40 1753 1763 18296102 10.1016/j.biocel.2008.01.013
15. SN Reske NM Blumstein B Neimaier HW Gottfried F Finsterbusch D Kocot, et al. 2006 Imaging prostate cancer with 11C-choline PET/CT J Nucl Med 47 1249 1254 16883001 1:CAS:528:DC%2BD28XptVWqu7w%3D
16. L Rinnab FM Mottaghy NM Blumstein SN Reske RE Hautman K Hohl, et al. 2007 Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer BJU Int 100 786 793 17822459 10.1111/j.1464-410X.2007.07083.x 1:CAS:528:DC%2BD2sXht1SmtLbK (Pubitemid 47360183)
17. Y Yamamoto Y Nishiyama R Kameyama K Okano H Kashiwagi A Deguchi, et al. 2008 Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET J Nucl Med 49 1245 1248 18632827 10.2967/jnumed.108.052639
18. M Cimitan R Bortolus S Morassut V Canzonieri A Garbeglio T Baresic, et al. 2006 [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Eur J Nucl Med Mol Imaging 33 1387 1398 16865395 10.1007/s00259-006-0150-2 (Pubitemid 44885404)
19. N Spaeth MT Wyss J Pahnke G Biollaz A Lutz K Goepfert, et al. 2006 Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2- deoxyglucose in F98 gliomas in the rat Eur J Nucl Med Mol Imaging 33 673 682 16538503 10.1007/s00259-005-0045-7 1:CAS:528:DC%2BD28Xlt1Kqsb4%3D (Pubitemid 43846758)
20. JN Talbot F Gutman L Fartoux JD Grange N Ganne K Kerrou, et al. 2006 PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT Eur J Nucl Med Mol Imaging 33 1285 1289 16802155 10.1007/s00259-006-0164-9 (Pubitemid 44630783)
21. A Bansal W Shuyan T Hara RA Harris TR DeGrado 2008 Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats Eur J Nucl Med Mol Imaging 35 1192 1203 18264706 10.1007/s00259-008-0736-y 1:CAS:528:DC%2BD1cXlvVClt7o%3D
22. RJ Raggers I Vogels G van Meer 2002 Upregulation of the expression of endogenous Mdr1 P-glycoprotein enhances lipid translocation in MDCK cells transfected with human MRP2 Histochem Cell Biol 117 181 185 11935294 10.1007/s00418-001-0352-4 1:CAS:528:DC%2BD38Xht1yktrk%3D (Pubitemid 34185624)
23. A van Helvoort AJ Smith H Sprong I Fritzsche AH Schinkel P Borst, et al. 1996 MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine Cell 87 507 517 8898203 10.1016/S0092-8674(00)81370-7 (Pubitemid 26374324)
24. C Vandeputte I Guizon I Genestie-Denis B Vannier G Lorenzon 1994 A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: performance study of a new miniaturized protocol Cell Biol Toxicol 10 415 421 7697505 10.1007/BF00755791 1:CAS:528: DyaK2MXjsF2nsbs%3D (Pubitemid 24377319)
25. N Le Jeune N Perek F Dubois 2006 Influence of Pi3-K and PKC activity on 99mTc-(V)-DMSA uptake: correlation with tumour aggressiveness in an in vitro malignant glioblastoma cell line model Eur J Nucl Med Mol Imaging 33 1206 1213 16763818 10.1007/s00259-006-0122-6 (Pubitemid 44484477)
26. KS Lips U Pfeil K Reiners C Rimasch K Kuchelmeister RC Braun-Dullaeus, et al. 2003 Expression of the high-affinity choline transporter CHT1 in rat and human arteries J Histochem Cytochem 51 1645 1654 14623932 1:CAS:528: DC%2BD3sXpsFGhur8%3D (Pubitemid 37475437)
27. MD Cordobes A Starzec L Delmon-Moingeon C Blanchot JC Kouyoumdjian G Prévost, et al. 1996 Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression J Nucl Med 37 286 289 8667063 1:CAS:528:DyaK28XhvVamu7Y%3D
28. D Kryza V Tadino MA Filannino G Villeret L Lemoucheux 2008 Fully automated [18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer Nucl Med Biol 35 255 260 18312837 10.1016/j.nucmedbio.2007.11.008 1:CAS:528:DC%2BD1cXhsl2hu70%3D (Pubitemid 351210702)
29. N Le Jeune N Perek D Denoyer F Dubois 2005 Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells Cancer Biother Radiopharm 20 249 259 15989470 10.1089/cbr.2005.20.249 (Pubitemid 41003830)
30. T Hara 2001 18F-fluorocholine: a new oncologic PET tracer J Nucl Med 42 1815 1817 11752078 1:STN:280:DC%2BD38%2FgtlOgsA%3D%3D
31. TC Hour J Chen CY Huang JY Guan SH Lu CY Hsieh, et al. 2000 Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines Anticancer Res 20 3221 3225 11062746 1:CAS:528:DC%2BD3cXnvVCjsb4%3D
32. E Mechetner A Kyshtoobayeva S Zonis H Kim R Stroup R Garcia, et al. 1998 Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin Clin Cancer Res 4 389 398 9516927 1:CAS:528:DyaK1cXhtlSmsbs%3D
33. Z Burak JL Moretti O Ersoy U Sanli M Kantar F Tamgac, et al. 2003 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression J Nucl Med 44 1394 1401 12960182 1:CAS:528:DC%2BD3sXnvVSrtrk%3D
34. S Del Vecchio A Ciarmiello M Salvatore 2000 Scintigraphic detection of multidrug resistance in cancer Cancer Biother Radiopharm 15 327 337 11041017 10.1089/cbr.2000.15.327 1:CAS:528:DC%2BD3cXntlyhtbk%3D
35. NH Hendrikse EJ Franssen WT van der Graaf C Meijer DA Piers W Vaalsburg, et al. 1998 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein Br J Cancer 77 353 358 9472628 1:CAS:528:DyaK1cXhtVyls7w%3D
36. JL Moretti M Duran Cordobes A Starzec V de Beco J Vergote F Benazzou, et al. 1998 Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells J Nucl Med 39 1214 1218 9669397 1:CAS:528:DyaK1cXkvVWltro%3D
37. B Drénou L Amiot T Lamy PY Le Prisé R Fauchet 1998 Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin Leuk Lymphoma 30 381 387 9713968
38. G Filomeni P Turella ML Dupuis O Forini MR Ciriolo M Cianfriglia, et al. 2008 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer Mol Cancer Ther 7 371 379 18281520 10.1158/1535-7163.MCT-07-0487 1:CAS:528:DC%2BD1cXitVShsrY%3D (Pubitemid 351302530)
39. K Scotlandi M Serra G Nicoletti M Vaccari MC Manara G Nini, et al. 1996 Multidrug resistance and malignancy in human osteosarcoma Cancer Res 56 2434 2439 8625324 1:CAS:528:DyaK28XivF2qsrY%3D
40. E Ackerstaff K Glunde ZM Bhujwalla 2003 Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem 90 525 533 14523987 10.1002/jcb.10659 1:CAS:528:DC%2BD3sXoslemsrs%3D (Pubitemid 37243700)
41. F Podo 1999 Tumour phospholipid metabolism NMR Biomed 12 413 439 10654290 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U 1:CAS:528:DC%2BD3cXnt1Gmuw%3D%3D (Pubitemid 30016999)
42. M Sarter V Parikh 2005 Choline transporters, cholinergic transmission and cognition Nat Rev Neurosci 6 48 56 15611726 10.1038/nrn1588 1:CAS:528:DC%2BD2cXhtVyqt77O (Pubitemid 40052138)
43. T Wang J Li F Chen Y Zhao X He D Wan, et al. 2007 Choline transporters in human lung adenocarcinoma: expression and functional implications Acta Biochim Biophys Sin (Shanghai) 39 668 674 10.1111/j.1745-7270.2007.00323.x 1:CAS:528:DC%2BD2sXhtF2hsb%2FK (Pubitemid 47437943)
44. M Carrella D Feldman S Cogoi A Csillaghy PA Weinhold 1999 Enhancement of mdr2 gene transcription mediates the biliary transfer of phosphatidylcholine supplied by an increased biosynthesis in the pravastatin-treated rat Hepatology 29 1825 1832 10347126 10.1002/hep.510290620 1:CAS:528:DyaK1MXjvFOmsLY%3D (Pubitemid 29247057)
45. T Hara A Bansal TR DeGrado 2006 Choline transporter as a novel target for molecular imaging of cancer Mol Imaging 5 498 509 17150162
46. S Kwee TR DeGrado JN Talbot F Gutman MN Coel 2007 Cancer imaging with fluorine-18-labeled choline derivatives Semin Nucl Med 37 420 428 17920349 10.1053/j.semnuclmed.2007.07.003 (Pubitemid 47498259)
47. TR DeGrado RE Coleman S Wang SW Baldwin MD Orr CN Robertson, et al. 2001 Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer Cancer Res 61 110 117 11196147 1:CAS:528:DC%2BD3MXlsl2lsA%3D%3D